IDEAS home Printed from https://ideas.repec.org/a/spr/pharmo/v9y2025i3d10.1007_s41669-025-00563-5.html
   My bibliography  Save this article

So Many Choices, So Little Value: Potential Savings from Selecting Cost-Effective Proton Pump Inhibitors

Author

Listed:
  • Hye-Young Kwon

    (Mokwon University)

Abstract

Background Given that Korea lacks measures to promote cost-effective prescribing, this study investigated the efficiency of prescribers’ decision-making when faced with the choice of 398 products containing 15 proton pump inhibitors (PPI). Objective This study aimed to explore PPI prescribing patterns in ambulatory care over 10 years and elucidate prescribers’ practices. Further analysis was conducted to estimate the achievable potential savings, assuming that the recommendation of first-choice drugs is based on the rational use of medicines. Methods Retrospective PPI prescribing data from the ambulatory sector pertaining to medical services provided to the entire South Korean population from 2013 to 2022 were extracted from the Korean National Health Information Database; the data were analyzed to identify annual trends in PPI spending and utilization volume according to defined daily doses (DDDs). Unit price per DDD was calculated, and a preferred cost-effective choice with identical efficacy and safety profile was selected among PPIs. The potential savings were then simulated using Dirichlet distribution. Results In ambulatory care, PPI drug costs increased by 13.0% per annum over 10 years. The preferred substances were esomeprazole (31.6%), rabeprazole (23.2%), and tegoprazan (16.5%), which are among the most expensive PPIs. However, the most cost-effective substance was dexlansoprazole (South Korean won [KRW] 522.7; standard deviation [SD] = 72.2; and median = 583). If dexlansoprazole is recommended as the first-choice PPI in the Korean context, the estimated cost savings would be 404.24 billion KRW, equivalent to 47.0% of the current PPI spending in ambulatory care. Conclusions This study identified opportunities for substantial cost savings related to PPI prescribing. Guided decision-making toward cost-effective PPI prescribing would increase the efficiency of prescribing and the sustainability of the healthcare system.

Suggested Citation

  • Hye-Young Kwon, 2025. "So Many Choices, So Little Value: Potential Savings from Selecting Cost-Effective Proton Pump Inhibitors," PharmacoEconomics - Open, Springer, vol. 9(3), pages 461-469, May.
    • Handle: RePEc:spr:pharmo:v:9:y:2025:i:3:d:10.1007_s41669-025-00563-5
    DOI: 10.1007/s41669-025-00563-5
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s41669-025-00563-5
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1007/s41669-025-00563-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharmo:v:9:y:2025:i:3:d:10.1007_s41669-025-00563-5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.